Stapled anoplin peptide combined with photothermal therapy enhances oncolytic immunotherapy of triple-negative breast cancer / 中国中药杂志

This study constructed a nano-drug delivery system, A3@GMH, by co-delivering the stapled anoplin peptide(Ano-3, A3) with the light-harvesting material graphene oxide(GO), and evaluated its oncolytic immunotherapy effect on triple-negative breast cancer(TNBC). A3@GMH was prepared using an emulsion template method and its physicochemical properties were characterized. The in vivo and in vitro photothermal conversion abilities of A3@GMH were investigated using an infrared thermal imager. The oncoly-tic activity of A3@GMH against TNBC 4T1 cells was evaluated through cell counting kit-8(CCK-8), lactate dehydrogenase(LDH) release, live/dead cell staining, and super-resolution microscopy. The targeting properties of A3@GMH on 4T1 cells were assessed using a high-content imaging system and flow cytometry. In vitro and in vivo studies were conducted to investigate the antitumor mechanism of A3@GMH in combination with photothermal therapy(PTT) through inducing immunogenic cell death(ICD) in 4T1 cells. The results showed that the prepared A3@GMH exhibited distinct mesoporous and coated structures with an average particle size of(308.9±7.5) nm and a surface potential of(-6.79±0.58) mV. The encapsulation efficiency and drug loading of A3 were 23.9%±0.6% and 20.5%±0.5%, respectively. A3@GMH demonstrated excellent photothermal conversion ability and biological safety. A3@GMH actively mediated oncolytic features such as 4T1 cell lysis and LDH release, as well as ICD effects, and showed enhanced in vitro antitumor activity when combined with PTT. In vivo, A3@GMH efficiently induced ICD effects with two rounds of PTT, activated the host's antitumor immune response, and effectively suppressed tumor growth in 4T1 tumor-bearing mice, achieving an 88.9% tumor inhibition rate with no apparent toxic side effects. This study suggests that the combination of stapled anoplin peptide and PTT significantly enhances the oncolytic immunotherapy for TNBC and provides a basis for the innovative application of anti-tumor peptides derived from TCM in TNBC treatment.

Advantages and disadvantages of magnetic resonance susceptibility effect applied clinically and countermeasures / 医疗卫生装备

Objective To explore the advantages and disadvantages of magnetic resonance susceptibility effect applied clinically and countermeasures. Methods The application range of susceptibility weighted imaging (SWI) technique and the harm of susceptibility artifact were introduced with considerations on MRI clinical application and experiences, and then some countermeasures were put forward accordingly. Results SWI technique could be used for the diagnoses of multi diseases, and susceptibility artifact could be suppressed by sequence, parameter and corresponding techniques. Conclusion Susceptibility effect contributes to extending the clinical application of MRI, and references are provided for the development and reform of other new techniques.

Endoscopic submucosal dissection for rectal carcinoid tumors / 中华胃肠外科杂志

<p><b>OBJECTIVE</b>To assess the clinical value of endoscopic submucosal dissection(ESD)for rectal carcinoid tumors.</p><p><b>METHODS</b>Endoscopic miniprobe ultrasonography was performed in patients with rectal submucosal tumors under colonoscope. ESD was carried out with the needle knife for lesions diagnosed as rectal carcinoid as following: (1)Fluid was injected into the submucosal layer in the rectum to elevate the lesion from the muscle layer. (2)The surrounding mucosa of the lesion was pre-cut. (3)The connective tissue of the submucosa beneath the lesion was dissected.</p><p><b>RESULTS</b>Five rectal carcinoids ranged from 0.4 to 1.2 cm and the mean resected size was 1.1 cm. All rectal carcinoid tumors were verified by pathological examination with lateral and basal resection margins free of tumor. The mean ESD procedure time (from fluid injection to complete dissection) was 35 min (ranged from 20 to 45 min). Minor bleeding occurred in all of the tumors, and none of patients had massive hemorrhage requiring blood transfusion or emergency colonoscopy due to hematochezia after ESD. One patient had subserosal emphysema due to deep tearing of the muscle layer, and recovered after several days' conservative treatment. All patients were followed up with colonoscopy 1 month after ESD,which confirmed the healing of artificial ulcers.</p><p><b>CONCLUSIONS</b>ESD is a novel endoscopic treatment that makes it possible to resect the whole rectal carcinoids. Rectal carcinoid tumors can now be treated by ESD to achieve the same therapeutic effect as operation.</p>

The application of artificial dermis and recombinant bFGF afer immersion bath in residual burn wound / 中华烧伤杂志

<p><b>OBJECTIVE</b>To observe the effect of application of a new type of artificial biological dressing and recombinant bull fibroblast growth factor( rb-FGF2) after immersion bath in the treatment of residual infected burn wounds at late postburn stage.</p><p><b>METHODS</b>Fifty-six patients with residual wounds at late postburn stage were enrolled in the study, and they were randomly divided into A( n = 28, experimental) and B (n = 28, control) groups. After treatment with immersion bath, the wounds in group A were treated with semi-exposure method. The wound were covered with suitable shape of biological dressings in suitable shape and rb-FGF2 spray twice a day after an immersion bath, and the dressing was changed every other day or every 2 days. To compare the treatment effect, the wounds in group B were only treated with a dressing of monolayer gauze wetted with povidone iodine. The clinical results, the bacteriological state findings, and the corresponding safety indices were determined 10 days after treatment.</p><p><b>RESULTS</b>The wound healing rate, efficacy and the bacterial clearance rate in A group were 64. 3% ,89. 3% ,92. 3% , respectively, and they were obviously higher than those in B group (32. 1% , 67. 9% , 72. 0% , respectively, P < 0. 01 ). No adverse side-effects were observed in either group.</p><p><b>CONCLUSION</b>Application of artificial dermis and bFGF after immersion bath is safe and effective for the elimination of residual wounds at late postburn stage, and it is also beneficial to control wound infection and promote the wound healing.</p>

Endoscopic interventional treatment of malignant gastrointestinal obstruction / 中华胃肠外科杂志

<p><b>OBJECTIVE</b>To evaluate the feasibility and clinical value of endoscopic interventional treatment of malignant gastrointestinal obstruction.</p><p><b>METHODS</b>With the aid of X ray, 32 cases with malignant gastrointestinal obstruction were treated with endoscopic metal stenting. There were 8 cases with gastric outlet obstruction, 7 with duodenal obstruction, 13 with rectal obstruction, and 4 with sigmoid obstruction.</p><p><b>RESULTS</b>Among the 32 patients, metal stenting was successfully performed in 30 cases (93.7%, and obstructive symptoms were relieved within 1-3 days. Metal stent placement was permanent in 15 cases with gastric outlet or duodenal obstruction. Twelve cases with colorectal obstruction received stent placement as palliative treatment, while other 3 cases underwent subsequent elective surgical resection. Metal stent placement failed in one case with recurrent rectal carcinoma, and perforation occurred in another one case with wide spread metastatic sigmoid colon carcinoma and Hartmann operation was performed. During the follow-up period, no stent migration was detected.</p><p><b>CONCLUSION</b>Endoscopic interventional treatment of malignant gastrointestinal obstruction is a feasible, safe, effective and well tolerated method. It can reduce the patients trauma and pain, and improve the quality of life.</p>

Clinical value of percutaneous endoscopic gastrostomy and jejunostomy / 中华胃肠外科杂志

<p><b>OBJECTIVE</b>To investigate the feasibility and safety of percutaneous endoscopic gastrostomy (PEG) and percutaneous endoscopic jejunostomy(PEJ).</p><p><b>METHODS</b>From June 1996 to April 2005, clinical data of 121 patients treated with PEG or PEJ were analyzed retrospectively.</p><p><b>RESULTS</b>A total of 121 patients experienced 134 times of PEG or PEG plus PEJ, including 90 cases (103 times) treated with PEG and 31 patients treated with PEG plus PEJ. Thirteen patients treated with PEG had fistula replacement 6-10 months after PEG. All patients had quick nutrition recovery after fistula tube insert,therefore parenteral nutrition was not required. No severe complications occurred in all patients after 10 months of following-up. Four patients had subcutaneous infection around fistula 4-10 days after PEG.</p><p><b>CONCLUSION</b>PEG and PEJ are safe and new methods for gastrointestinal decompression and enteral nutrition, which can be substitutes for nasogastric tube.</p>